Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from China Traditional Chinese Medicine Holdings Co ( (HK:0570) ).
China Traditional Chinese Medicine Holdings Co. announced a board change, with non-executive director Liu Haijian resigning due to a change in work arrangements and stepping down from the remuneration and evaluation committee. Liu stated he has no disagreements with the board and no issues needing shareholder attention, and the company expressed appreciation for his contributions.
The company simultaneously appointed Chen Kun as a non-executive director and member of the remuneration and evaluation committee, effective 15 May 2026. Chen brings a compliance, supervision and state-owned enterprise governance background from roles at the People’s Bank of China, discipline inspection bodies and China National Pharmaceutical Group, and will serve an initial three-year term, with his director’s fee paid by CNPGC rather than the company.
The most recent analyst rating on (HK:0570) stock is a Sell with a HK$1.60 price target. To see the full list of analyst forecasts on China Traditional Chinese Medicine Holdings Co stock, see the HK:0570 Stock Forecast page.
More about China Traditional Chinese Medicine Holdings Co
China Traditional Chinese Medicine Holdings Co. Limited is a Hong Kong-incorporated company engaged in the traditional Chinese medicine sector through its subsidiaries. The group operates within the broader pharmaceutical industry, focusing on Chinese medicine products and related healthcare services in mainland China and international markets.
Average Trading Volume: 13,588,648
Technical Sentiment Signal: Sell
Current Market Cap: HK$8.26B
See more data about 0570 stock on TipRanks’ Stock Analysis page.